65 related articles for article (PubMed ID: 3020455)
21. Behavior of cervical intraepithelial neoplasia (CIN) associated with various human papillomavirus (HPV) types.
Hellberg D; Nilsson S; Gad A; Hongxiu J; Fuju C; Syrjänen S; Syrjänen K; Grad A [corrected to Gad A]
Arch Gynecol Obstet; 1993; 252(3):119-28. PubMed ID: 8389112
[TBL] [Abstract][Full Text] [Related]
22. Natural killer (NK) cells with HNK-1 phenotype in the cervical biopsies of women followed-up for human papillomavirus (HPV) lesions.
Syrjänen K; Väyrynen M; Mäntyjärvi R; Castren O; Saarikoski S
Acta Obstet Gynecol Scand; 1986; 65(2):139-45. PubMed ID: 3014803
[TBL] [Abstract][Full Text] [Related]
23. Immunocompetent cells in uterine cervical lesions of human papillomavirus origin.
Syrjänen KJ
Gynecol Obstet Invest; 1983; 16(6):327-40. PubMed ID: 6317528
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of human papillomavirus in the survival of cervical cancer patients: an overview of the evidence.
Franco EL
Cancer Epidemiol Biomarkers Prev; 1992; 1(6):499-504. PubMed ID: 1338870
[TBL] [Abstract][Full Text] [Related]
25. Langerhans cells in human papillomavirus (HPV) lesions of the uterine cervix identified by the monoclonal antibody OKT-6.
Väyrynen M; Syrjänen K; Mäntyjärvi R; Castrén O; Saarikoski S
Int J Gynaecol Obstet; 1984 Oct; 22(5):375-83. PubMed ID: 6151923
[TBL] [Abstract][Full Text] [Related]
26. Colposcopy in assessment of the natural history of prospectively followed-up human papillomavirus (HPV) lesions in the uterine cervix.
Väyrynen M
Acta Obstet Gynecol Scand; 1986; 65(5):493-9. PubMed ID: 3022539
[TBL] [Abstract][Full Text] [Related]
27. Chlamydial cervicitis in women followed-up for human papillomavirus (HPV) lesions of the uterine cervix.
Syrjänen K; Mäntyjärvi R; Väyrynen M; Castrén O; Yliskoski M; Saarikoski S
Acta Obstet Gynecol Scand; 1985; 64(6):467-71. PubMed ID: 2998147
[TBL] [Abstract][Full Text] [Related]
28. Altered expression of filaggrin in human papillomavirus (HPV) lesions of the uterine cervix.
Cintorino M; Syrjänen S; Leoncini P; Bellizzi De Marco E; Petracca R; Pallini V; Tosi P; Mäntyjärvi R; Syrjänen K
Arch Gynecol Obstet; 1988; 241(4):235-47. PubMed ID: 2835017
[TBL] [Abstract][Full Text] [Related]
29. Immunophenotypes of lymphocytes in prospectively followed up human papillomavirus lesions of the cervix.
Väyrynen M; Syrjänen K; Mäntyjärvi R; Castrén O; Saarikoski S
Genitourin Med; 1985 Jun; 61(3):190-6. PubMed ID: 2989155
[TBL] [Abstract][Full Text] [Related]
30. The relation between the type of immunoreactive cells found in human papillomavirus (HPV) lesions of the uterine cervix and the subsequent behaviour of these lesions.
Syrjänen K; Väyrynen M; Castrén O; Mäntyjärvi R; Yliskoski M
Arch Gynecol; 1984; 234(3):189-96. PubMed ID: 6203493
[TBL] [Abstract][Full Text] [Related]
31. [Data on the role of the human papillomavirus in the carcinogenesis of the uterine cervix].
Nemes J; Gergely L; Czeglédy J; Pintér A; Dömötör L; Avar Z; Várnai F
Orv Hetil; 1988 Oct; 129(44):2347-51. PubMed ID: 2847101
[No Abstract] [Full Text] [Related]
32. Factors associated with progression of cervical human papillomavirus (HPV) infections into carcinoma in situ during a long-term prospective follow-up.
Syrjänen K; Mäntyjärvi R; Saarikoski S; Väyrynen M; Syrjänen S; Parkkinen S; Yliskoski M; Saastamoinen J; Castren O
Br J Obstet Gynaecol; 1988 Nov; 95(11):1096-102. PubMed ID: 2849985
[TBL] [Abstract][Full Text] [Related]
33. Natural killer cells in cervical intraepithelial neoplasia and human papillomavirus infection.
Tay SK; Jenkins D; Singer A
Br J Obstet Gynaecol; 1987 Sep; 94(9):901-6. PubMed ID: 2822078
[TBL] [Abstract][Full Text] [Related]
34. Electron microscopic detection of human papillomavirus particles in oral proliferative lesions.
Broich G; Sasaki T
Bull Tokyo Dent Coll; 1989 Nov; 30(4):213-20. PubMed ID: 2561816
[TBL] [Abstract][Full Text] [Related]
35. Expression of cytokeratin No. 19 polypeptide in genital papillomavirus lesions.
Leoncini P; Petracca R; Ruggiero P; Cintorino M; Syrjänen S; Mäntyjärvi R; Syrjänen K
Gynecol Obstet Invest; 1990; 29(1):59-66. PubMed ID: 1693587
[TBL] [Abstract][Full Text] [Related]
36. Immunoperoxidase demonstration of human papilloma virus (HPV) in dysplastic lesions of the uterine cervix.
Syrjänen KJ; Pyrhönen S
Arch Gynecol; 1982; 233(1):53-61. PubMed ID: 6299212
[TBL] [Abstract][Full Text] [Related]
37. [New strain of cells derived from the cancer tissue of the human uterine cervix--with a special reference to their origin and characteristics].
Hamazaki M
Nihon Sanka Fujinka Gakkai Zasshi; 1970 Feb; 22(2):79-86. PubMed ID: 5462593
[No Abstract] [Full Text] [Related]
38. Papillomavirus infection in greenfinches (Carduelis chloris).
Sironi G; Gallazzi D
Zentralbl Veterinarmed B; 1992 Aug; 39(6):454-8. PubMed ID: 1329406
[TBL] [Abstract][Full Text] [Related]
39. Electron microscopy what izzits.
Bockus D; Remington F; Friedman S; Hammar S
Ultrastruct Pathol; 1985; 9(1-2):1-30. PubMed ID: 3003989
[No Abstract] [Full Text] [Related]
40. A clinicopathological study of episomal papillomavirus infection of the human placenta and pregnancy complications.
Slatter TL; Hung NG; Clow WM; Royds JA; Devenish CJ; Hung NA
Mod Pathol; 2015 Oct; 28(10):1369-82. PubMed ID: 26293778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
